TRACON Pharmaceuticals's total assets for Q2 2024 were $7.40M, a decrease of -20.90% from the previous quarter. TCON total liabilities were $10.49M for the fiscal quarter, a -5.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.